NEW DELHI, JAN. 26: Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech’s nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The world’s first made-in-India intranasal vaccine was launched at Mandaviya’s residence here. The nasal vaccine — BBV154 — had Continue Reading
Hyderabad,Dec.27 : Bharat Biotech International Limited on Tuesday said its covid-19 intranasal vaccine iNCOVACC, which is now available on CoWIN portal, is priced at Rs 800 (excluding GST) for private markets and Rs 325 (excluding GST) for government supplies. A press release from the vaccine maker said the jab will be rolled out in the […]Continue Reading
HYDERABAD, NOV 6: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said. Due to lack of product demand, production stoppage of Covaxin- a two dose jab, was initiated by Bharat Biotech […]Continue Reading
Hyderabad.April 3 : The World Health Organization (WHO) has confirmed it has suspended the supply of Covaxin, produced by city-based Bharat Biotech, through UN procurement agencies and recommending to countries that received the covid vaccine to take actions as appropriate. A statement issued by WHO on Saturday said the suspension is in response to the […]Continue Reading